Cargando…
High Dose Pharmaceutical Grade Biotin (MD1003) Accelerates Differentiation of Murine and Grafted Human Oligodendrocyte Progenitor Cells In Vivo
Accumulating evidences suggest a strong correlation between metabolic changes and neurodegeneration in CNS demyelinating diseases such as multiple sclerosis (MS). Biotin, an essential cofactor for five carboxylases, is expressed by oligodendrocytes and involved in fatty acid synthesis and energy pro...
Autores principales: | Levy, Marion J. F., Garcia-Diaz, Beatriz, Sedel, Frédéric, Baron-Van Evercooren, Anne, Mozafari, Sabah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778913/ https://www.ncbi.nlm.nih.gov/pubmed/36555377 http://dx.doi.org/10.3390/ijms232415733 |
Ejemplares similares
-
High-dose pharmaceutical grade biotin (MD1003) in amyotrophic lateral sclerosis: A pilot study
por: Juntas-Morales, Raul, et al.
Publicado: (2020) -
Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high‐dose pharmaceutical‐grade biotin (MD1003)
por: Collongues, Nicolas, et al.
Publicado: (2020) -
MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study
por: Tourbah, Ayman, et al.
Publicado: (2018) -
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
por: Tourbah, Ayman, et al.
Publicado: (2016) -
Differential requirement of cyclin-dependent kinase 2 for oligodendrocyte progenitor cell proliferation and differentiation
por: Caillava, Céline, et al.
Publicado: (2012)